Koninklijke Philips NV, also known as Royal Philips, is an international technology company headquartered in Amsterdam, Netherlands. The company's primary divisions include Philips Consumer Lifestyle, Philips Healthcare, and Philips Lighting. Its common stock is traded under the symbol "PHG" on the New York Stock Exchange in the form of American Depositary Receipts (ADRs).
Royal Philips was founded in 1891 by Gerard Philips and his father, as a small light bulb factory. From its humble beginnings, the company has grown to become a global leader in health technology, committed to improving people's health and well-being. With an extensive history of innovation, having introduced the first medical X-ray tube in 1918, Philips is recognized as spearheading progress in several areas of healthcare, including cardiology, oncology, and home health care.
In consumer electronics, Philips' reputation is garnered from pioneering significant progress in the television, radio, and music sectors. The Audio Compact Cassette and Compact Disc, both developed by Philips, reshaped the landscape of the music industry. Its lighting division also plays a major role in energy-efficient lighting solutions and new lighting applications.
Philips' vision is to make the world healthier and more sustainable through innovation, aiming to improve the lives of 2.5 billion people a year by 2030. To achieve this, Philips invests heavily in Research & Development, seeking breakthrough innovations that resonate with consumers' health and lifestyle needs.
Despite the company's successful history, Philips continues to evolve and innovate. In recent years, it has transitioned to a health technology enterprise, shedding off its traditional lighting and consumer electronics segments. Now, Philips Healthcare represents the lion's share of the company's revenue, predicated upon diagnostic imaging, patient monitoring, image-guided therapy, and health informatics.
Moreover, the company's exemplar sustainability drive is clearly manifested in its ECO vision program, whose aim it is to decrease its carbon footprint and increase its energy efficiency drastically.
As an ADR, Philips provides an opportunity for U.S. investors to invest in the company without the complications of purchasing shares in foreign markets. Each Philips ADR represents shares in Philips NV and trades in U.S. dollars. American depositary shares aim to reduce administration costs and simplify trading for U.S. investors.
Overall, Koninklijke Philips NV remains a major multi-national corporation, distinguishing itself in the fields of health technology, consumer lifestyle, and lighting. With its focus firmly set on improving lives via meaningful innovations, Philips continues its consistent growth and commitment to societal impact.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Koninklijke Philips N.V. (NYSE:PHG) has received an average "Hold" rating from five brokerages, with all covering analysts issuing hold or neutral recommendations. This consensus follows Zacks Research upgrading the stock from "strong sell" to "hold" and UBS reiterating its "neutral" view. Despite institutional investors increasing their positions and the company beating quarterly EPS and revenue estimates, its revenue declined 3% year-over-year, and shares opened near their 12-month low.
Baird Financial Group Inc. has acquired 42,669 new shares of Koninklijke Philips N.V. (NYSE:PHG) during the second quarter, valued at approximately $1.16 million. Other institutional investors like Royal Bank of Canada and Bank of America Corp DE also increased their holdings. Koninklijke Philips recently reported strong quarterly earnings, beating consensus estimates with $0.57 EPS and $4.98 billion in revenue, though revenue declined 3% year-over-year.
Tidal Investments LLC significantly increased its stake in Koninklijke Philips N.V. (NYSE:PHG) by 18.9% in the second quarter of 2026, now owning over 400,000 shares valued at approximately $10.9 million. The company reported strong Q2 earnings, beating analyst expectations with $0.57 EPS and $4.98 billion in revenue, despite a 3% year-over-year revenue decline. Koninklijke Philips currently holds a consensus "Hold" rating from analysts, with the stock trading near its 52-week low.
Royal Philips has launched the Philips Lumea IPL 9900 Pro, an at-home IPL device featuring real-time audio guidance and motion tracking via an app, making it the first of its kind. This innovation aims to enhance user confidence and treatment effectiveness, promising up to five years of smooth skin with minimal maintenance. The device, which has U.S. FDA clearance, incorporates intelligent SenseIQ Pro sensor technology for personalized and safe treatment, and is now available for purchase.
Philips has expanded its women's health ultrasound portfolio with the launch of the eV14-2v transvaginal transducer, designed for gynecology and early obstetrics imaging. This new transducer improves workflow efficiency and diagnostic capabilities by offering enhanced penetration, better image quality, and a wider field of view. The launch strengthens Philips' position in the premium ultrasound market and is expected to contribute to the growing global obstetrics & gynecology ultrasound devices market.
Philips has introduced the eV14-2v transvaginal transducer, expanding its ultrasound range for obstetrics and gynaecology. This new device, which has received FDA 510(k) clearance and a CE mark, offers improved penetration, 2D resolution, and field of view, alongside a lighter design. It is designed for use with Philips Collaboration Live, allowing remote clinicians to provide guidance during examinations.
A Delaware federal court jury has ordered China's Quectel to pay Philips $3 million for infringing a patent related to 3G and 4G wireless technology. The jury also found Quectel's infringement to be willful, potentially tripling the damages award. Philips expressed satisfaction with the verdict, stating it acknowledges the value of their innovations and intellectual property.
Royal Philips has successfully priced an offering of EUR 650 million fixed rate notes due 2034, marking the healthcare industry's first EU Green Bond under the new European Green Bond Standard. The issuance, with a coupon of 4.0% and a yield of 4.055%, will finance taxonomy-aligned economic activities supporting Philips' 2030 Impact Ambition. This move is not expected to increase Net Debt, with temporary Gross Debt increase until a 2027 bond maturity repayment.